precision medicine Archives
Achilles’ heel for kidney cancer
Feb. 28, 2019—The discovery that kidney cells with mutations in a certain gene are sensitive to therapies called PI3K inhibitors opens new opportunities for applying precision medicine to cancer treatment.
Investigators map genomic landscape of very rare cancer
Feb. 28, 2019—A team of Vanderbilt researchers mapped out the genomic landscape of a metastatic malignant proliferating tricholemmal tumor and identified a targeted treatment for this very rare cancer.
Grant supports novel imaging initiative to enhance cancer care
Jan. 31, 2019—A Vanderbilt initiative to develop predictive imaging technologies that clinicians can use to better match patients with personalized care has received National Cancer Institute (NCI) funding.
Ethics study explores precision medicine’s risks, rewards
Nov. 29, 2018—Precision medicine research — which involves the consolidation of massive amounts of complex data and the widespread sharing of those data for a variety of research studies — offers the prospect of both benefit and harm.
Event set to launch ‘All of Us’ personalized medicine initiative
May. 3, 2018—The All of Us Research Program, which aims to accelerate the prevention and treatment of illness through precision medicine with the help of a million or more research participants across the United States, officially opens for national enrollment Sunday, May 6.
Wilkins takes key role in national ‘All of Us’ precision medicine effort
Apr. 26, 2018—Consuelo Wilkins, MD, MSCI, has played a major role in the development of the national All of Us Research Program, an ambitious effort led by the National Institutes of Health (NIH) to accelerate the prevention and treatment of illness through precision medicine.
Precision medicine discussion
Oct. 26, 2017—Consuelo Wilkins, M.D., MSCI, and Joshua Denny, M.D., M.S., discussed the potential of precision medicine during their recent Flexner Discovery Lecture.
Denny, Wilkins to discuss precision medicine at next Discovery Lecture
Oct. 5, 2017—Joshua Denny, M.D., M.S., and Consuelo Wilkins, M.D., MSCI, will discuss the potential of “precision medicine” during the next Vanderbilt Cutting-Edge Discovery Lecture on Thursday, Oct. 12.
VUMC chosen for leadership role in NIH Precision Medicine Initiative Cohort Program
Jul. 7, 2016—Vanderbilt University Medical Center has been chosen by the National Institutes of Health to be a leader in a landmark study of genetic, environmental and lifestyle factors affecting the health of a million or more people. The NIH will provide $71.6 million over five years to VUMC, making this the largest research grant the Medical Center has ever received from any source.
VUMC chosen for leadership role in NIH Precision Medicine Initiative Cohort Program
Jul. 7, 2016—Vanderbilt University Medical Center (VUMC) has been chosen by the National Institutes of Health (NIH) to be the Data and Research Support Center for the Precision Medicine Initiative Cohort Program, a landmark study of genetic, environmental and lifestyle factors affecting the health of a million or more people, federal officials have announced.
NIH awards $11.6 million grant to Vanderbilt, Miami and Meharry for new center to study precision medicine and health disparities
May. 25, 2016—Researchers at Vanderbilt University Medical Center (VUMC), the University of Miami and Meharry Medical College were recently awarded a five-year, $11.6 million grant to launch a new center that will enable research using precision medicine to eradicate health disparities, specifically those among African-Americans and Latinos.
Study looks at doctors’ response to genetic testing
Mar. 31, 2016—A new clinical implementation study from Vanderbilt University Medical Center measures how physicians have responded to the introduction of routine genetic testing to predict patient response to the commonly prescribed antiplatelet drug clopidogrel.
